# Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

> **NCT00566813** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 10 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Islet Cell Transplant
- **DRUG:** Islet Cell Transplant plus

## Key facts

- **NCT ID:** NCT00566813
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2010-07-05
- **Final completion:** 2020-07-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566813, "Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00566813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*